ArticleRSC advances2018

Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52-ssDNA association.

Jian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.